跳至主要内容
临床试验/NCT04548401
NCT04548401Unknown不适用

Effect of Antiplatelet Therapy on Cognition After Aneurysmal Subarachnoid Hemorrhage

Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Montreal Cognitive Assessment (MoCA) Test

研究概览

简要总结

Deficits in memory, executive function, and language are common cognitive sequelae of aneurysmal subarachnoid hemorrhage (aSAH). Previous study demonstrated that post-treatment antiplatelet therapy reduced risk for delayed cerebral ischemia caused by aSAH. However, the effect of antiplatelet therapy on cognition after aSAH is unclear. The aim of this study was to assess the effect of antiplatelet therapy on cognition after aSAH.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with SAH in whom the aneurysm was proven by conventional angiography;
  • •Baseline Hunt-Hess grade I-III;
  • •patients received endovascular treatment

排除标准

  • •Hunt-Hess grade IV-V;
  • •Non-aneurysmal SAH;
  • •Dementia in other diseases;
  • •Lacking of 6-8 month MoCA evaluation.

研究组 & 干预措施

Antiplatelet-Y group

Patients with ruptured aneurysm underwent stent assisted coiling, with post-treatment antiplatelet therapy (aspirin and/or clopidogrel or ticagrelor)

干预措施: Antiplatelet Drug (Drug)

结局指标

主要结局

Montreal Cognitive Assessment (MoCA) Test

时间窗: 6-8 months

次要结局

未报告次要终点

研究者

发起方
Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hai-Bin Shi

Professor

Nanjing Medical University

研究点 (1)

Loading locations...

相似试验